Gilead Sciences, Inc. (GILD)
149.61
-0.31
(-0.21%)
USD |
NASDAQ |
Sep 02, 16:00
149.63
+0.02
(+0.01%)
After-Hours: 17:53
Gilead Sciences Market Cap : 185.67B for Sept. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 186.05B |
| August 31, 2026 | 181.61B |
| August 28, 2026 | 180.79B |
| August 27, 2026 | 184.74B |
| August 26, 2026 | 183.78B |
| August 25, 2026 | 184.62B |
| August 24, 2026 | 182.10B |
| August 21, 2026 | 181.33B |
| August 20, 2026 | 178.01B |
| August 19, 2026 | 183.17B |
| August 18, 2026 | 178.01B |
| August 17, 2026 | 172.40B |
| August 14, 2026 | 171.70B |
| August 13, 2026 | 171.43B |
| August 12, 2026 | 168.61B |
| August 11, 2026 | 168.49B |
| August 10, 2026 | 165.13B |
| August 07, 2026 | 165.31B |
| August 06, 2026 | 162.40B |
| August 05, 2026 | 163.51B |
| August 04, 2026 | 167.85B |
| August 03, 2026 | 162.76B |
| July 31, 2026 | 161.72B |
| July 30, 2026 | 163.05B |
| July 29, 2026 | 164.85B |
| Date | Value |
|---|---|
| July 28, 2026 | 166.83B |
| July 27, 2026 | 162.11B |
| July 24, 2026 | 160.60B |
| July 23, 2026 | 162.53B |
| July 22, 2026 | 161.88B |
| July 21, 2026 | 161.81B |
| July 20, 2026 | 165.45B |
| July 17, 2026 | 166.78B |
| July 16, 2026 | 169.28B |
| July 15, 2026 | 163.57B |
| July 14, 2026 | 161.51B |
| July 13, 2026 | 163.20B |
| July 10, 2026 | 161.25B |
| July 09, 2026 | 167.47B |
| July 08, 2026 | 168.69B |
| July 07, 2026 | 169.36B |
| July 06, 2026 | 160.98B |
| July 02, 2026 | 163.04B |
| July 01, 2026 | 156.45B |
| June 30, 2026 | 156.91B |
| June 29, 2026 | 156.90B |
| June 26, 2026 | 158.83B |
| June 25, 2026 | 153.81B |
| June 24, 2026 | 155.45B |
| June 23, 2026 | 155.31B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 141.04B |
| AbbVie, Inc. | 462.39B |
| Regeneron Pharmaceuticals, Inc. | 88.13B |
| Amgen, Inc. | 239.38B |
| Biogen, Inc. | 32.89B |
Market Cap Related Metrics
| PS Ratio | 6.128 |
| Price to Book Value | 15.70 |
| Price to Free Cash Flow | 14.46 |
| Price | 149.61 |
| Earnings Yield | -1.78% |
| Operating PE Ratio | 15.69 |
| Normalized PE Ratio | 31.49 |